Publication:
Methylchloroisothiazolinone / methylisothiazolinone: epidemiological retrospective study.

Simple item page
dc.contributor.authorLorente-Lavirgen, A I
dc.contributor.authorAlmeida, C
dc.contributor.authorBernabeu, J
dc.contributor.authorValero, V
dc.contributor.authorLorente, R
dc.date.accessioned2023-01-25T13:33:23Z
dc.date.available2023-01-25T13:33:23Z
dc.date.issued2019-03-11
dc.description.abstractAllergic contact dermatitis (ACD) is a common problem confronted in clinical practice and several authors have started to point to MCI/MI as an emerging allergen primary present in many daily cosmetic (1,2) since late 80s. The present study was carried out to described the epidemiological characteristic of patients with ACD to MCI/MI during a 10 years period. We want to elucidate factors associated and identify the clinical and epidemiological features of patients with ACD to MCI/MI.
dc.description.versionNo
dc.identifier.citationLorente-Lavirgen AI, Almeida C, Bernabeu J, Valero V, Lorente R. Methylchloroisothiazolinone/methylisothiazolinone: epidemiological retrospective study. Eur Ann Allergy Clin Immunol. 2019 May 15;51(3):131-134
dc.identifier.doi10.23822/EurAnnACI.1764-1489.92
dc.identifier.issn1764-1489
dc.identifier.pmid31081605
dc.identifier.unpaywallURLhttp://www.eurannallergyimm.com/cont/journals-articles/700/volume-methylchloroisothiazolinone-methylisothiazolinone-epidemiological-retrospective-study-3127allasp1.pdf
dc.identifier.urihttp://hdl.handle.net/10668/13945
dc.issue.number3
dc.journal.titleEuropean annals of allergy and clinical immunology
dc.journal.titleabbreviationEur Ann Allergy Clin Immunol
dc.language.isoen
dc.organizationIBIS
dc.page.number4
dc.provenanceRealizada la curación de contenido 18/09/2024
dc.publisherEdizioni Edra
dc.pubmedtypeLetter
dc.relation.publisherversionhttps://doi.org/10.23822/EurAnnACI.1764-1489.92
dc.rights.accessRightsopen access
dc.subjectallergic contact dermatitis
dc.subjectatopic dermatitis
dc.subjectmethylchloroisothiazolinone / methylisothiazolinone (MCI/ MI)
dc.subjectpreservants
dc.subject.decsAdolescent
dc.subject.decsAdult
dc.subject.decsAged, 80 and over
dc.subject.decsAnti-Infective Agents
dc.subject.decsDermatitis, Allergic Contact
dc.subject.meshAdolescent
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshAnti-Infective Agents
dc.subject.meshDermatitis, Allergic Contact
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshPatch Tests
dc.subject.meshRetrospective Studies
dc.subject.meshSpain
dc.subject.meshThiazoles
dc.subject.meshYoung Adult
dc.titleMethylchloroisothiazolinone / methylisothiazolinone: epidemiological retrospective study.
dc.typeLetter to the editor
dc.type.hasVersionVoR
dc.volume.number51
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Lorente_Methylchloroisothiazolinone.pdf
Size:
76.11 KB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario Virgen del Rocío

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía